A study by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute suggests a way to re-energize critical killer immune cells that have become exhausted when fighting cancer or chronic viral infections.
Moffitt Cancer Center researchers, led by cancer biologist Eric Lau, demonstrated how L-fucose, a nontoxic dietary plant sugar that is enriched in red and brown seaweeds, can increase tumor infiltrating lymphocytes, promote antitumor immunity, and improve the efficacy of immunotherapy.
A four-drug chemotherapy regimen provided longer overall survival than a two-drug combination in a phase III clinical trial for metastatic pancreatic ductal adenocarcinoma.
According to a large study led by researchers at the American Cancer Society, the risk of suicide for individuals diagnosed with cancer in the United States is 26% higher, compared with the general population.
A MUSC Hollings Cancer Center pilot trial evaluating brief tele-cognitive behavioral therapy developed specifically for head and neck cancer survivors with body-image distress showed promising results.
Adding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival time for patients with advanced biliary tract cancers, but it may provide a benefit for subsets of patients with locally-advanced disease or gallbladder adenocarcinoma.
Research in the January 2023 issue of the Journal of the National Comprehensive Cancer Network finds that immunotherapy from PD-1 inhibitors prior to surgery was strikingly effective for patients with localized mismatch repair-deficient or microsatellite instability-high colorectal cancer.
A study, conducted by UC Davis Comprehensive Cancer Center researchers, shows an alarming number of California women 65 and older are facing late-stage cervical cancer diagnoses and dying from the disease, despite guidelines that recommend most women stop screening for cervical cancer at this age.
A study led by investigators from the Mass General Cancer Center, a member of Mass General Brigham, in collaboration with researchers at the Massachusetts Institute of Technology, developed and tested an artificial intelligence tool that accurately predicted the risk of lung cancer for individuals with or without a significant smoking history.
Cooling brain tumor cells to stop them from dividing without killing healthy cells extended the survival of glioblastoma animal models dramatically in a study led by a UT Southwestern resident.
